The director of Farmaindustria’s Access department analyses the challenges in the access of these patients to pharmaceutical innovation at a conference of the Spanish Society of […]

International Clinical Trials Day commemorates the importance of clinical trials every 20 May Clinical trials advance medicine and address unmet medical needs Source: farmaindustria.es In the […]

The Deputy Director General of Farmaindustria, Javier Urzay, recalls that this is a key moment to define the country’s strategy in research to face the new […]

This measure allows for greater participation and the inclusion of a more diverse population, which improves the scientific quality of the studies, as highlighted by Farmaindustria’s […]

In the opinion of the employers’ association, it “represents yet another barrier to patient access to innovative treatments” Source: espaciosanitario.com Following the proposed revision of the […]

Farmaindustria brings together in Spain the main European National Associations representing the innovative pharmaceutical industry and the European Federation of the Pharmaceutical Industry together with the […]

Farmaindustria states that it is “the first sectoral code approved by the AEPD and a reference at European level” Source: espaciosanitario.com Farmaindustria has announced that a […]

Source: elperiodico.com Multiple sclerosis is an autoimmune disease of the central nervous system that affects the brain and spinal cord. It is caused by damage to […]

Data from the Spanish Clinical Trials Register reveal the commitment of the pharmaceutical industry, which finances 88% of trials with paediatric patients. Incentives for innovation are […]

Oncology is one of the key issues on the health agenda that Spain will take to the Presidency of the Council of the European Union in […]

Farmaindustria’s Director of Access, Isabel Pineros, analyses the current challenges of access to therapeutic innovation at the Spanish Summit against Cancer, organised by Gepac “We must […]

2021 closes with the best R&D investment figures ever: the pharmaceutical industry allocates 1,267 million euros to both private and public projects. Source: elespanol.com Investing in […]

The project is called Borders should no longer be barriers and has been promoted by Efpia and the European Good Clinical Practice Forum, in collaboration with […]

25% of the studies authorised last year are already for orphan drugs to combat rare diseases 86% of trials are driven by the pharmaceutical industry Javier […]

The pharmaceutical industry in Spain has a total of 103 production plants, a figure that rises to 173 when active ingredients and veterinary medicines are added […]

The figure reached in 2021 is 9% higher than in 2020, when, despite the pandemic, the sector achieved the second best record in its history up […]

A Dutch team has developed a cell therapy for metastatic melanoma that improves on the current standard. Source: elespanol.com Researchers in the Netherlands and Denmark have […]

Representatives of scientific societies, public administrations, researchers and pharmaceutical companies make up the group. Clinical research at this level of care has a great opportunity for […]

Source: actasanitaria.com This report outlines the medicines already assessed by the Spanish Agency for Medicines and Health Products (AEMPS), which are considered to be of greatest interest […]

A study by Professor Lichtenberg of Columbia University attributes up to 96% of the increase in life expectancy in cancer patients and a high degree of […]

Increased international competitiveness and digitalisation will require more investment in infrastructure and resources to ensure that our country remains at the forefront of biomedical R&D Source: […]

Farmaindustria explains to Esclerosis Múltiple Euskadi what these studies consist of, how to take part in them and how research into this pathology is progressing Source: […]

Aerospace and defence investment is eight times higher than in the aerospace and defence industry, seven times higher than in the chemical industry, and twice as […]

Oncology, infectious diseases, neurology, haematology and endocrinology are the areas with the highest number of clinical trials with new treatments underway. Seven out of ten molecules […]

Farmaindustria explains to some twenty experts some of the policies and initiatives that have made Spain an international benchmark in clinical drug trials Source: farmaindustria.es Representatives […]

Farmaindustria organises workshops with representatives of the Spanish Data Protection Agency and the Spanish Medicines Agency to continue working on the implementation of the new Code […]

In the framework of its General Assembly, held in Madrid Source: www.actasanitaria.com In the framework of its General Assembly, held in Madrid, Farmaindustria has highlighted, this […]

Representatives of patients’ associations, researchers and experts in health economics debate in the newspaper El Español on the link between health, the economy and the well-being […]